VIT logo

Vitura Health Limited Stock Price

ASX:VIT Community·AU$41.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

VIT Share Price Performance

AU$0
-0.08 (-100.00%)
AU$0
-0.08 (-100.00%)
Price AU$0

VIT Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and slightly overvalued.

2 Risks
1 Reward

Vitura Health Limited Key Details

AU$124.0m

Revenue

AU$90.3m

Cost of Revenue

AU$33.8m

Gross Profit

AU$30.4m

Other Expenses

AU$3.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.005
27.21%
2.68%
19.4%
View Full Analysis

About VIT

Founded
2018
Employees
n/a
CEO
Geoffrey Cockerill
WebsiteView website
vitura.com.au

Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual healthcare services; BHC, an alternative therapy distributor; CDA Clinics, which provides medicinal consultations and prescription services; and Cannadoc, a therapy clinic that offers telehealth consultations. It also offers psychedelics under the Cortexa brand; Adaya which provides hybrid formulations and Australian-cultivated products; candor medical that provides care to patients; and inscape, which offers crafted formulations for individual needs. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. Vitura Health Limited was incorporated in 2018 and is based in South Yarra, Australia.

Recent VIT News & Updates

Recent updates

No updates